TOP TIERMARKET NEWSWIRE

News & sentiment

NUVATION BIO INC A Class A (NUVB) — News & AI sentiment

NUVATION BIO INC A Class A (NUVB) news roundup. 4 stories aggregated over the last 30 days. Average 30-day sentiment is 56/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $709K — net selling of $709K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

0

30d stories

4

avg sentiment 56/100

Insider net (90d)

$709K

0 buys · 1 sells

Congress (90d)

0

0 buys · 0 sells

NUVB news in the last 24 hours, 7 days, 30 days and 90 days

How much NUVB coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	NUVB stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	0	—	no coverage
Last 30 days	4	56/100	NUVB headlines →
Last 90 days	40	60.6/100	NUVB headlines →

Latest stories on NUVB

Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026

StockTitan50 · neutralgeneral

Oct 21

Citizens reiterates Nuvation Bio stock rating on launch execution

Investing.com Analyst Ratings52 · neutralanalyst

Oct 19

Nuvation, Jazz gain new Buys at Citi on oncology prospects

Seeking Alpha61 · neutralanalyst

Sep 30

Nuvation Bio initiated with a Buy at Citi

The Fly61 · neutralanalyst

Sep 30

NUVB highlights nearly 50-month median response as FDA updates IBTROZI label ahead of schedule September 18, 2026

MarketChameleon73 · bullishproduct/pr

Sep 18

Why is Nuvation Bio stock surging today?

Investing.com Markets50 · neutralgeneral

Sep 17

Nuvation Bio stock gains on FDA label update for IBTROZI

Investing.com Markets63 · neutralproduct/pr

Sep 17

Nuvation Bio rises on FDA label update for Ibtrozi

Seeking Alpha63 · neutralgeneral

Sep 17

NUVB Wins FDA Label Update for IBTROZI Highlighting 49.70-Month Median Response Duration September 17, 2026

MarketChameleon73 · bullishproduct/pr

Sep 17

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

The Fly78 · bullishproduct/pr

Sep 17

Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer

PR Newswire78 · bullishproduct/pr

Sep 17

Citizens maintains Nuvation Bio stock rating on competitive edge

Investing.com Analyst Ratings56 · neutralanalyst

Sep 16

Nuvation Bio Inc. (NUVB) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

Seeking Alpha56 · neutralproduct/pr

Sep 15

Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer

PR Newswire67 · bullishproduct/pr

Sep 15

Nuvation Bio Inc. (NUVB) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Seeking Alpha56 · neutralgeneral

Sep 9

Lightning Round: I would own GE Vernova over Nuscale, says Jim Cramer

CNBC56 · neutralanalyst

Sep 4

Cramer's lightning round: Nuvation Bio 'is a pure spec'

CNBC42 · neutralanalyst

Sep 3

Nuvation Bio to Participate in Upcoming Investor Conferences

PR Newswire56 · neutralgeneral

Sep 2

Nuvation: Why I'm Downgrading To Hold Despite Progress On NSCLC And Glioma Fronts

Seeking Alpha46 · neutralanalyst

Aug 26

Why is Nuvation Bio stock rallying today?

Investing.com Markets50 · neutralgeneral

Aug 21

Nuvation Bio stock rises after Cantor starts at Overweight

Investing.com Markets63 · neutralanalyst

Aug 21

Nuvation Bio rises as Cantor initiates at overweight

Seeking Alpha63 · neutralanalyst

Aug 21

Cantor Fitzgerald initiates Nuvation Bio stock with overweight rating

Investing.com Analyst Ratings61 · neutralanalyst

Aug 21

Nuvation Bio initiated with an Overweight at Cantor Fitzgerald

The Fly61 · neutralanalyst

Aug 21

FDA Fast Track Designation for Safusidenib Highlights Nuvation Bio’s Breakthrough in IDH1-Mutant Glioma August 20, 2026

MarketChameleon73 · bullishproduct/pr

Aug 20

Open NUVB in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →